A. L. Mak

发表

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease

P. Bossuyt, M. Nieuwdorp, M. Tushuizen, 2021, Journal of clinical medicine.

Calcineurin inhibitors augment endothelial-to-mesenchymal transition by enhancing proliferation in association with cytokine-mediated activation.

Z. Haskova, D. Briscoe, C. Woda, 2019, Biochemical and biophysical research communications.

Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

P. Bossuyt, M. Nieuwdorp, J. Schattenberg, 2021, Biomedicines.

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study

B. H. van den Born, H. Galenkamp, Y. Vali, 2022, Hepatology communications.

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease

A. Nederveen, U. Beuers, O. Gurney-Champion, 2022, Frontiers in Physiology.

Non-Alcoholic Fatty Liver Disease: A Multidisciplinary Approach Towards A Cardiometabolic Liver Disease.

U. Beuers, M. Tushuizen, A. Holleboom, 2020, European journal of endocrinology.

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort

A. Zwinderman, R. Sinkus, M. Nieuwdorp, 2021, Journal of magnetic resonance imaging : JMRI.

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.

V. Wong, V. de Lédinghen, P. Bossuyt, 2023, The lancet. Gastroenterology & hepatology.

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach

E. Levin, P. Henneman, Daniela Stols-Gonçalves, 2023, Gut microbes.

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting in non-alcoholic fatty liver disease.

A. Nederveen, U. Beuers, O. Gurney-Champion, 2022, medRxiv.

Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

M. Tushuizen, A. Holleboom, Anne-Marieke van Dijk, 2024, Clinical Chemistry and Laboratory Medicine.

Validation of the enhanced liver ﬁ brosis (ELF)-test in heparinized and EDTA plasma for use in re ﬂ ex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

M. Tushuizen, A. Holleboom, J. Witjes, 2022 .

Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice

P. A. de Jonge, H. Herrema, A. Meijnikman, 2024, International journal of molecular sciences.